Skyward Specialty Insurance (NASDAQ:SKWD) misses Q3 2026 sales expectations

Skyward Specialty Insurance (SKWD) reported Q3 2026 revenue of $455.3M, up 19% YoY but missing estimates by 9%. EPS beat expectations at $1.09. Net premiums earned grew 15.7% YoY but missed estimates by 15.7%. Book value per share rose 21% YoY to $28.74, slightly missing estimates. CEO Andrew Robinson highlighted strong performance and growth strategies. Shares fell 4.8% post-earnings.

Original reporting
Published Nov 5, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Skyward Specialty Insurance (NASDAQ:SKWD) misses Q3 2026 sales expectations — source image
Decision brief

The 30-second read

$SKWDBearishMed
01

Why it matters

The miss may trigger short‑term sell‑offs, though the company's fee‑based model and underwriting profitability provide a defensive cushion.

02

Market read

Earnings miss leads to immediate price decline; traders may adjust positions based on revenue expectations versus earnings quality.

03

What to watch

Fee‑based revenue growth and a solid combined ratio suggest underlying operational strength not reflected in the revenue miss.

Relevance 7/10Novelty 8/10Timing: after-hours reaction

Background

Skyward Specialty Insurance reported Q3 2026 results with revenue below consensus but a modest EPS beat and a strong combined ratio.

Company-level read

Ticker impact

$SKWDBearishHigh confidence
Context

Q3 2026 results missed revenue estimates and shares fell 4.8% after the release.

Expected impact

likely pressure as the market prices in the revenue miss and share decline

Evidence & confidence

Revenue fell short of consensus, EPS beat was modest, and the stock dropped 4.8% immediately, indicating bearish sentiment.

Market effects

Insurance sector may see modest pressure as peers' earnings expectations are re-evaluated.

U.S. specialty insurers could face heightened scrutiny on revenue forecasts.

Limited to specialty insurance niche; no broad market impact.

Counterpoint

Despite the miss, the 1.5% EPS beat and strong combined ratio could support a longer‑term buy on valuation.

Key entities

  • Skyward Specialty Insurance

    Specialty insurer listed on NASDAQ (SKWD) reporting Q3 2026 earnings.

Related articles

$SKWDHighAI 8/10

Raymond James reiterates Strong Buy on Skyward Specialty stock

Raymond James reiterated a Strong Buy rating and $75.00 price target for Skyward Specialty Insurance Group (NASDAQ:SKWD), citing strong value and growth prospects. The stock has risen 39% in six months. Q3 2026 net investment income increased 54% YoY to $34 million. Management prioritizes debt repayment over share buybacks. Raymond James raised its 2026 EPS estimate to $5.10. Skyward reported Q3 EPS of $1.28, beating estimates by 42.2%, with revenue at $501.77 million.

$SKWDMed

Jefferies raises Skyward Specialty Insurance stock price target to $64

Jefferies increased its price target for Skyward Specialty Insurance (NASDAQ:SKWD) to $64, maintaining a Hold rating. The firm cited the company's diversification and attractive valuation, but noted rising competition. Skyward reported Q3 2026 earnings of $1.28 per share, exceeding estimates, with revenue of $501.77 million. The stock declined due to competitive pressures and lack of 2027 guidance.

$SKWDHighAI 8/10

Skyward (SKWD) Q3 2026 Earnings Call Transcript

Skyward (SKWD) reported Q3 2026 earnings with operating income of $58M ($1.28 per diluted share) and 9M operating income of $175M. Gross written premiums rose 9% to $803M, with fee-generating premiums up 18% to $517M. Combined ratio was 89.9%, and operating return on equity exceeded 20%. Skyward Specialty saw 10% premium growth, while Apollo's premiums increased 3%, with fee income up 18%.

$SKWDMed

Skyward Specialty Insurance Group Q3 Earnings Call Highlights

Skyward Specialty Insurance Group reported a 13% rise in net earned premiums for the first nine months, with Q3 combined ratio at 88.3. Lower dairy and livestock coverage uptake and treaty year adjustments affected growth. Apollo's gross written premiums increased 3%, with fee-generating premiums up 18%. The company launched new initiatives and expects to provide 2027 guidance in Q4. Book value per share rose 15% to $28.74, with net investment income up 54%.

$SKWDMed

Skyward: Q3 Earnings Snapshot

Skyward Specialty Insurance Group (SKWD) reported Q3 profit of $49.8M, or $1.09 per share, beating analyst estimates of $1.22 per share. Adjusted earnings were $1.28 per share. Revenue was $455.3M, missing expectations of $507.3M.